Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhenhua Jeremy Wu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Genome Research|November 4, 2010
Gene expression profiling of human breast tissue samples using SAGE-SeqZhenhua Jeremy Wu, Clifford A Meyer, Sibgat Choudhury, et al.
Clinical Lung Cancer|May 12, 2026
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLCMarina Chiara Garassino, Sophie Cousin, Benjamin Besse, et al.
Cancer Cell|September 14, 2013
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cellsWai Leong Tam, Haihui Lu, Joyce Buikhuisen, et al.
Nature Communications|January 13, 2019
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulatorsDaniel Aird, Teng Teng, Chia-Ling Huang, et al.
Science (New York, N.Y.)|December 15, 2012
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independentKexin Xu, Zhenhua Jeremy Wu, Anna C Groner, et al.
Nature Communications|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complexTeng Teng, Jennifer Hc Tsai, Xiaoling Puyang, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Genome Research|November 4, 2010
Gene expression profiling of human breast tissue samples using SAGE-SeqZhenhua Jeremy Wu, Clifford A Meyer, Sibgat Choudhury, et al.
Clinical Lung Cancer|May 12, 2026
ENTRÉE Lung Platform Trial Sub-study 1: Phase II Randomized Efficacy and Safety Analysis of Feladilimab Plus Docetaxel Versus Docetaxel Monotherapy in Advanced/Recurrent NSCLCMarina Chiara Garassino, Sophie Cousin, Benjamin Besse, et al.
Cancer Cell|September 14, 2013
Protein kinase C α is a central signaling node and therapeutic target for breast cancer stem cellsWai Leong Tam, Haihui Lu, Joyce Buikhuisen, et al.
Nature Communications|January 13, 2019
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulatorsDaniel Aird, Teng Teng, Chia-Ling Huang, et al.
Science (New York, N.Y.)|December 15, 2012
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independentKexin Xu, Zhenhua Jeremy Wu, Anna C Groner, et al.
Nature Communications|May 26, 2017
Splicing modulators act at the branch point adenosine binding pocket defined by the PHF5A-SF3b complexTeng Teng, Jennifer Hc Tsai, Xiaoling Puyang, et al.
Nature Communications|July 26, 2017
Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Nature Communications|June 6, 2019
Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancerManav Korpal, Xiaoling Puyang, Zhenhua Jeremy Wu, et al.
Pageof 1